• Dietary GDF11 Delays Aging via Smad2/3 Antioxidant Pathway i

  2026-04-25

  This study demonstrates that oral administration of yeast-displayed GDF11 delays aging biomarkers and enhances antioxidant enzyme activity in male mice, primarily through activation of the Smad2/3 pathway. The findings clarify the mechanistic role of the TGF-β signaling axis in aging, offering a well-controlled in vivo platform for further pathway-targeting research.

• Sulfo-Cy3 Azide: Shaping Translational Neurogenetics

  2026-04-24

  This thought-leadership article explores how the mechanistic properties of Sulfo-Cy3 azide, a next-generation bioconjugation reagent, are transforming Click Chemistry fluorescent labeling in developmental neuroanatomy. We bridge recent discoveries in claustrum neurogenesis with actionable guidance for translational researchers, highlighting protocol best practices and the unique advantages of APExBIO’s hydrophilic dye for high-fidelity, aqueous-phase labeling. By integrating insights from landmark studies and advanced workflow scenarios, the article challenges conventional product overviews and charts a forward-looking roadmap for the field.

• Benzyl Quinolone Carboxylic Acid: Selective M1 Receptor Pote

  2026-04-24

  Benzyl Quinolone Carboxylic Acid (BQCA) is a highly selective positive allosteric modulator of the M1 muscarinic acetylcholine receptor. It enhances acetylcholine signaling with over 100-fold selectivity for M1 over other muscarinic subtypes, offering a valuable tool for cognitive and Alzheimer's disease research. APExBIO's BQCA (SKU: C3869) demonstrates robust brain penetration and reproducible pharmacological benchmarks.

• Nadolol (SQ-11725): Dissecting Transporter-Driven PK in Card

  2026-04-23

  Explore the nuanced pharmacokinetic interplay of Nadolol (SQ-11725) in cardiovascular models, with a focus on transporter-mediated variability and assay optimization. This article delivers unique insights for hypertension research, setting it apart from existing protocol-driven guides.

• Benzyl Quinolone Carboxylic Acid: Elevating M1 Receptor Assa

  2026-04-23

  Benzyl Quinolone Carboxylic Acid (BQCA) uniquely amplifies M1 muscarinic acetylcholine receptor signaling, enabling highly selective, reproducible modulation for cognitive and Alzheimer's disease research. This guide presents experimental workflows, protocol parameters, and troubleshooting strategies to maximize BQCA’s experimental value in neuronal and signal transduction assays.

• Caspase-4 Colorimetric Assay: Translational Strategies Unloc

  2026-04-22

  This article delivers a thought-leadership perspective for translational researchers, blending mechanistic insights on caspase-4 and inflammasome biology with actionable guidance for experimental design, biomarker selection, and therapeutic hypothesis generation. It situates the Caspase-4 Colorimetric Assay Kit within the evolving landscape of cell fate modulation, drawing parallels with advanced organelle-targeted strategies, and provides a nuanced protocol guide for robust, reproducible results.

• TAK1 Stabilizes YAP to Drive Gastric Cancer Stem Cell Renewa

  2026-04-22

  This study uncovers how TGFβ-activated kinase 1 (TAK1) upregulation in gastric cancer stabilizes yes-associated protein (YAP), promoting self-renewal and oncogenesis of gastric cancer stem cells (GCSCs). These findings clarify a key regulatory axis in tumorigenesis and suggest new molecular targets for cancer research and potential therapy development.

• Clinical and Economic Evidence for Dabigatran in Stroke Prev

  2026-04-21

  This review article critically evaluates dabigatran's clinical efficacy, safety, and cost-effectiveness as an oral direct thrombin inhibitor for stroke prevention in nonvalvular atrial fibrillation and venous thromboembolism. The findings highlight dabigatran's distinct clinical advantages and drawbacks compared to traditional anticoagulants, guiding both therapeutic and research applications.

• Omeprazole (A2845): Technical Guidance for H+,K+-ATPase Inhi

  2026-04-21

  Omeprazole (SKU A2845) is a high-purity, potent H+,K+-ATPase inhibitor widely used in gastric acid secretion and antiulcer activity research. It is not suitable for clinical, diagnostic, or cross-domain applications beyond proton pump inhibition studies. Researchers should be aware of its solubility and storage characteristics for optimal performance.

• PTBP2 Attenuation Enhances Fibroblast-to-Neuron Transdiffere

  2026-04-20

  This study demonstrates that knockdown of PTBP2, a neuronal RNA splicing regulator, significantly increases the efficiency of converting human skin fibroblasts into GABAergic neurons by promoting neuron-specific alternative splicing. The findings clarify mechanisms underlying direct neuronal reprogramming and highlight the interplay between PTBP2 and RBFOX3 in neuronal fate determination.

• Refining In Vitro Drug Response: Insights from Cancer System

  2026-04-20

  Schwartz's dissertation advances the evaluation of anti-cancer agents by dissecting the nuanced relationship between drug-induced growth inhibition and cell death, highlighting the non-equivalence of commonly used viability metrics. These findings inform more precise in vitro assay design and interpretation, directly impacting the reliability of preclinical cancer drug research.

• KPT-330 (Selinexor): Applied Workflows for Cancer Research

  2026-04-19

  KPT-330 (Selinexor) empowers oncology researchers to dissect nuclear export mechanisms, induce apoptosis, and inhibit tumor growth across challenging cancer models. This article provides practical guidance on experimental setup, protocol optimization, and troubleshooting to ensure robust, reproducible results with APExBIO’s validated CRM1 inhibitor.

• Indomethacin Sodium Trihydrate: Targeting PSCs in Tumor Micr

  2026-04-18

  Explore how Indomethacin Sodium Trihydrate modulates pancreatic stellate cell activation and the tumor microenvironment through COX-2 inhibition. This in-depth analysis provides unique mechanistic insights and practical assay guidance for anti-inflammatory research.

• Omeprazole (A2845): Protocol Guidance for H+,K+-ATPase Inhib

  2026-04-17

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor intended strictly for research applications in gastric acid secretion studies, antiulcer activity, and peptic ulcer disease models. It should not be used for diagnostic or clinical purposes, and its efficacy and protocols are grounded in well-defined physicochemical properties and laboratory workflow recommendations.

• (S)-Mephenytoin in CYP2C19 Organoid Assays: Next-Gen PK Insi

  2026-04-16

  This article investigates the intersection of (S)-Mephenytoin as a gold-standard CYP2C19 substrate and the transformative potential of hiPSC-derived intestinal organoids for human-relevant pharmacokinetic studies. It delivers mechanistic clarity, comparative context, and strategic guidance for translational researchers seeking superior predictivity in oxidative drug metabolism assays, with protocol parameters, evidence labeling, and critical discussion of limitations and future directions.

14949 records 1/997 page Next 12345 下5页 Last page